Inventor · disambiguated record
Fabio E. S. Souza
Also filed as: SOUZA FABIO E S
28 granted patents·11 pending applications·48 citations·filing 2007–2024
93Inventor score
Top patents by PatentIndex Score
39 records- 0195US11377456B2Crystalline form of RemdesivirAPOTEX INC·Filed 2021·Granted Jul 5, 2022·16 cites·21 claims
- 0291US9278979B2Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful thereinALPHORA RES INC·Filed 2013·Granted Mar 8, 2016·21 cites·5 claims
- 0384US10487059B2Crystalline form of EluxadolineAPOTEX INC·Filed 2018·Granted Nov 26, 2019·2 cites·7 claims
- 0484US10183024B2Crystalline forms of ibrutinibAPOTEX INC·Filed 2017·Granted Jan 22, 2019·2 cites·5 claims
- 0580US11236066B2Crystalline forms of niraparib tosylateAPOTEX INC·Filed 2020·Granted Feb 1, 2022·1 cites·20 claims
- 0679US10513504B2Processes for the preparation of apalutamide and intermediates thereofAPOTEX INC·Filed 2019·Granted Dec 24, 2019·2 cites·19 claims
- 0778US11046638B2Processes for the preparation of zuclomiphene and intermediates thereofAPOTEX INC·Filed 2020·Granted Jun 29, 2021·1 cites·17 claims
- 0876US9062020B22-((2S,3S,4R,5R)-5-((S)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparationALPHORA RES INC·Filed 2012·Granted Jun 23, 2015·2 cites·21 claims
- 0970US11814356B1Salt of cabozantinibAPOTEX INC·Filed 2023·Granted Nov 14, 2023·0 cites·16 claims
- 1068US10822309B2Crystalline form of EluxadolineAPOTEX INC·Filed 2019·Granted Nov 3, 2020·0 cites·9 claims
- 1168US9695187B2Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful thereinALPHORA RES INC·Filed 2016·Granted Jul 4, 2017·1 cites·4 claims
- 1265US2024409547A1Solid Forms of UpadacitinibAPOTEX INC·Filed 2024·Application pending·0 cites
- 1364US2024116884A1Salts of ViloxazineAPOTEX INC·Filed 2023·Application pending·0 cites
- 1463US10611772B2Crystalline form of Ribociclib succinateAPOTEX INC·Filed 2019·Granted Apr 7, 2020·0 cites·11 claims
- 1563US2024018090A1Processes for the Preparation of FenfluramineAPOTEX INC·Filed 2023·Application pending·0 cites
- 1660US11667656B2Crystalline forms of Tenofovir alafenamideAPOTEX INC·Filed 2021·Granted Jun 6, 2023·0 cites·20 claims
- 1760US11578025B2Processes for the preparation of zuclomiphene intermediatesAPOTEX INC·Filed 2021·Granted Feb 14, 2023·0 cites·16 claims
- 1860US2025049774A1Crystalline Forms of ApalutamideAPOTEX INC·Filed 2022·Application pending·0 cites
- 1959US10662178B2Crystalline form of OlaparibAPOTEX INC·Filed 2019·Granted May 26, 2020·0 cites·14 claims
- 2059US10407396B2Crystalline form of selexipagAPOTEX INC·Filed 2018·Granted Sep 10, 2019·0 cites·19 claims
- 2159US2025019346A1Salts of Ruxolitinib and Crystalline Forms ThereofAPOTEX INC·Filed 2022·Application pending·0 cites
- 2256US9174956B2Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereofALPHORA RES INC·Filed 2012·Granted Nov 3, 2015·0 cites·14 claims
- 2355US11661396B2Crystalline forms of zuclomiphene citrateAPOTEX INC·Filed 2021·Granted May 30, 2023·0 cites·23 claims
- 2455US11072620B2Crystalline forms of Ponatinib hydrochlorideAPOTEX INC·Filed 2018·Granted Jul 27, 2021·0 cites·16 claims
- 2555US10858346B2Crystalline form of lumacaftorAPOTEX INC·Filed 2018·Granted Dec 8, 2020·0 cites·19 claims
- 2655US2023093124A1Salts of Nintedanib and Crystalline Forms ThereofAPOTEX INC·Filed 2022·Application pending·0 cites
- 2754US11345706B2Crystalline forms of AcalabrutinibAPOTEX INC·Filed 2018·Granted May 31, 2022·0 cites·9 claims
- 2854US2008312465A1Intermediate compounds in the synthesis of dronabinolALPHORA RES INC·Filed 2007·Application pending·0 cites
- 2953US10632107B2Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2APOTEX INC·Filed 2019·Granted Apr 28, 2020·0 cites·16 claims
- 3053US9416140B2Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereofALPHORA RES INC·Filed 2015·Granted Aug 16, 2016·0 cites·14 claims
- 3152US9650397B23-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereofALPHORA RES INC·Filed 2014·Granted May 16, 2017·0 cites·9 claims
- 3251US11440871B2Zuclomiphene salts and crystalline forms thereofAPOTEX INC·Filed 2020·Granted Sep 13, 2022·0 cites·9 claims
- 3351US2023279036A1Salts of RemdesivirAPOTEX INC·Filed 2021·Application pending·0 cites
- 3450US2021292272A1Salts of ZuclomipheneAPOTEX INC·Filed 2021·Application pending·0 cites
- 3549US2019390235A1Processes for the Preparation of Dasotraline and Intermediates ThereofAPOTEX INC·Filed 2019·Application pending·0 cites
- 3648US9850254B2Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing-SO2-(p-tolyl) groupsALPHORA RES INC·Filed 2014·Granted Dec 26, 2017·0 cites·14 claims
- 3746US9181152B2Process for preparation of (3R)-2,4-di-leaving group-3-methylbut-1-eneALPHORA RES INC·Filed 2012·Granted Nov 10, 2015·0 cites·22 claims
- 3846US2020317616A1Crystalline Form of Betrixaban MaleateAPOTEX INC·Filed 2020·Application pending·0 cites
- 3938US10301274B2Crystalline derivatives of (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-YL)-3-aminopropan-2-olSANDOZ AG·Filed 2015·Granted May 28, 2019·0 cites·38 claims
Join the waitlist — get patent alerts
Get an alert when Fabio E. S. Souza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →